Rein Therapeutics
RNTX
#9653
Rank
NZ$62.9 M
Marketcap
$2.86
Share price
3.03%
Change (1 day)
-66.23%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2024 (TTM): -NZ$48.03 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$25.83 Million, an increase over its 2022 earnings that were of -NZ$46.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$48.03 Million85.97%
2023 -NZ$25.83 Million-44.49%
2022 -NZ$46.52 Million3.92%
2021 -NZ$44.77 Million29.81%
2020 -NZ$34.49 Million-31.58%
2019 -NZ$50.4 Million-6.1%
2018 -NZ$53.68 Million38.66%
2017 -NZ$38.71 Million26.63%
2016 -NZ$30.57 Million